- Home
- PLRX vs SWBI Comparison
PLRX vs SWBI Comparison
Compare PLRX & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- SWBI
- Stock Information
- Founded
- PLRX 2015
- SWBI 1852
- Country
- PLRX United States
- SWBI United States
- Employees
- PLRX N/A
- SWBI N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- SWBI Ordnance And Accessories
- Sector
- PLRX Health Care
- SWBI Industrials
- Exchange
- PLRX Nasdaq
- SWBI Nasdaq
- Market Cap
- PLRX 641.5M
- SWBI 587.1M
- IPO Year
- PLRX 2020
- SWBI N/A
- Fundamental
- Price
- PLRX $14.72
- SWBI $11.03
- Analyst Decision
- PLRX Strong Buy
- SWBI Hold
- Analyst Count
- PLRX 7
- SWBI 2
- Target Price
- PLRX $40.50
- SWBI $13.00
- AVG Volume (30 Days)
- PLRX 459.1K
- SWBI 854.2K
- Earning Date
- PLRX 11-07-2024
- SWBI 12-05-2024
- Dividend Yield
- PLRX N/A
- SWBI 4.75%
- EPS Growth
- PLRX N/A
- SWBI 23.33
- EPS
- PLRX N/A
- SWBI 0.79
- Revenue
- PLRX N/A
- SWBI $514,645,000.00
- Revenue This Year
- PLRX N/A
- SWBI $6.69
- Revenue Next Year
- PLRX N/A
- SWBI $6.31
- P/E Ratio
- PLRX N/A
- SWBI $13.95
- Revenue Growth
- PLRX N/A
- SWBI 0.32
- 52 Week Low
- PLRX $10.22
- SWBI $10.43
- 52 Week High
- PLRX $19.62
- SWBI $18.05
- Technical
- Relative Strength Index (RSI)
- PLRX 56.15
- SWBI 31.67
- Support Level
- PLRX $13.14
- SWBI $10.66
- Resistance Level
- PLRX $15.27
- SWBI $11.13
- Average True Range (ATR)
- PLRX 0.75
- SWBI 0.40
- MACD
- PLRX 0.00
- SWBI -0.19
- Stochastic Oscillator
- PLRX 58.27
- SWBI 14.06
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.